Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-24T01:33:51.008Z Has data issue: false hasContentIssue false
  • English
  • Français

Situational and psycho-social factors associated with relapse following residential detoxification in a population of Irish opioid dependent patients

Published online by Cambridge University Press:  13 June 2014

Kevin Ducray ,
Catherine Darker  and
Bobby P Smyth
Kevin Ducray*
Affiliation:
The Drug Treatment Centre Board, 30-31 Pearse Street, Dublin 2, Ireland
Catherine Darker
Affiliation:
Department of Public Health and Primary Care, Trinity College, Dublin 2, Ireland
Bobby P Smyth
Affiliation:
The Drug Treatment Centre Board, 30-31 Pearse Street, Dublin 2, Ireland Department of Public Health and Primary Care, Trinity College, Dublin 2, Ireland
*
*Correspondence E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Aims: To identify and describe the context and factors involved in the opioid lapse process following discharge from an Irish inpatient opioid detoxification treatment programme.

Design, participants, setting: Prospective follow-up study of consecutive detoxified opioid dependent patients treated in a specialist inpatient drug dependency unit.

Measurements: The Maudsley Addiction Profile and a structured interview were administered to 109 patients, 18–36 months after discharge.

Findings: Of 109 people interviewed at follow-up, 102 (94%) reported at least one episode of opioid use after leaving the residential treatment programme. Eighty eight patients (86% of the lapsers) identified more than one major factor contributing to their recidivism. The median number of factors identified as having a major role in the lapse was four. The most frequently reported major contributors to lapse were low mood (62%), difficulties with craving (62%), ease of access to heroin (48%) and missing the support of the treatment centre (43%).

Conclusions: Early lapse was common following inpatient treatment of opioid dependence. Lapse tended to result from a number of common, identifiable, high-risk situations, feelings and cognitions which may assist clinicians and patients develop lapse prevention strategies to anticipate and interrupt this process.

Keywords

Lapserelapseopioidsheroinrelapse- preventionpsychologicaldrugaddictionabstinencesocial.
Type
Original Paper
Information
Irish Journal of Psychological Medicine , Volume 29 , Issue 2 , 2012 , pp. 72 - 79
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Comiskey, C, Cox, G. ROSIE baseline data report. Dublin: National Advisory Committee on Drugs; 2007.Google Scholar
2.Callon, C, Wood, E, Marsh, D, Li, K, Montaner, J, Kerr, T. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. J Opioid Manag 2006 01-Feb; 2(1):35–41.CrossRefGoogle Scholar
3.Marsch, LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998 Apr; 93(4):515–32.CrossRefGoogle ScholarPubMed
4.McKeganey, N. The challenge to UK drug policy. Drug-Educ Prev Policy 2007; 14 (6):559–571.CrossRefGoogle Scholar
5.Hubbard, RL, Craddock, SG, Anderson, J. Overview of 5-year follow up outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003 10; 25(3):125–34.CrossRefGoogle ScholarPubMed
6.Strang, J, McCambridge, J, Best, D, Beswick, T, Bearn, J, Rees, S, Gossop, M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003 05; 326(7396):959–60.CrossRefGoogle ScholarPubMed
7.Day, E. Opiate detoxification in an inpatient setting. London: National Treatment Agency for Substance Misuse, 2005.Google Scholar
8.Comptroller Auditor General VFM Report 64. Drug Addiction Treatment & Rehabilitation. Dublin: Office of the Comptroller Auditor General, 2009.Google Scholar
9.Farrell, M, Barry, J. The introduction of the opioid treatment protocol. Dublin: Health Service Executive, 2010.Google Scholar
10.Van den Brink, W, Haasen, C. Evidence-based treatment of opioid-dependent patients. Can J Psychiatry 2006 09; 51 (10): 635–46.CrossRefGoogle ScholarPubMed
11.National Drugs Strategy 2001–2008: Building on Experience. Dublin: Department of Tourism, Sport and Recreation, 2001.Google Scholar
12.National Drugs Strategy (interim) 2009-2016. Dublin: Department of Community, Rural and Gaeltacht Affairs, 2009.Google Scholar
13.Haug, NA, Sorensen, JL, Gruber, VA, Song, JS. Relapse prevention for opioid dependence. In: Marlatt, GA, Donovan, DM, editors. Relapse Prevention. 2nd ed. New York: Guilford Press; 2005. P 151–78.Google Scholar
14.Witkiewitz, K, Marlatt, GA. Modeling the complexity of post-treatment drinking: it's a rocky road to relapse. Clin Psychol Rev 2007 07; 27(6):724–38.CrossRefGoogle ScholarPubMed
15.Ockene, JK, Emmons, KM, Mermelstein, RJ, Perkins, KA, Bonollo, DS, Voorhees, CC, Hollis, JF. Relapse and maintenance issues for smoking cessation. Health Psychol 2000 01; 19(1 Suppl):17–31.CrossRefGoogle ScholarPubMed
16.Litman, GK, Stapleton, J, Oppenheim, AN, Peleg, M, Jackson, P. Situations related to alcoholism relapse. Br J Addict 1983 12; 78(4):381–9.CrossRefGoogle ScholarPubMed
17.Amato, L, Minozzi, S, Davoli, M, Vecchi, S, Ferri, M, Mayet, S. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Cochrane Database Syst Rev 2008 10; (4): CD005031. Review.Google Scholar
18.Fugelstad, A, Stenbacka, M, Leifman, A, Nylander, M and Thiblin, I. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. Addiction 2007; 102(3): 406–412.CrossRefGoogle ScholarPubMed
19.Naderi-Heiden, A, Gleiss, A, Bäcker, C, Bieber, D, Nassan-Agha, H, Kasper, S, Frey, R. Mortality and employment after in-patient opiate detoxification. European Psychiatry: the journal of the Association of European Psychiatrists 2010 07: 0924-9338.Google ScholarPubMed
20.Marlatt, GA. Relapse Prevention: Theoretical rational and overview of the model. In: Marlatt, GA, Gordon, JR, editors. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press; 1985. p 3–70.Google Scholar
21.Donovan, DM. Assessment of addictive behaviors for relapse prevention. In: Donovan, DM, Marlatt, GA, editors. Assessment of addictive behaviors. New York: Guilford Press; 2005. p 1–48.Google Scholar
22.Shiffman, S. Conceptual issues in the study of relapse. In: Gossop, M, editor. Relapse and addictive behaviour. London: Routledge; 1989. p 149–79.Google Scholar
23.Donovan, DM. Marlatt's classification of relapse precipitants: is the Emperor still wearing clothes?Addiction 1996 12; 91 Suppl: S131–7.Google Scholar
24.Witkiewitz, K, Marlatt, GA. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am Psychol 2004 05-Jun; 59(4):224–35.CrossRefGoogle ScholarPubMed
25.Hunter-Reel, D, McCrady, B, Hildebrandt, T. Emphasizing interpersonal factors: an extension of the Witkiewitz and Marlatt relapse model. Addiction 2009; 104: 1281–1290.CrossRefGoogle ScholarPubMed
26.Bradley, BP, Phillips, G, Green, L, Gossop, M. Circumstances surrounding the initial lapse to opiate use following detoxification. Br J Psychiatry 1989 03; 154: 354–9.CrossRefGoogle ScholarPubMed
27.Westermeyer, J. Nontreatment factors affecting treatment outcome in substance abuse. Am J Drug Alcohol Abuse 1989; 15(1): 13–29.CrossRefGoogle ScholarPubMed
28.Gossop, M, Green, L, Phillips, G, Bradley, B. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry 1989 03; 154: 348–53.CrossRefGoogle ScholarPubMed
29.Unnithan, S, Gossop, M, Strang, J. Factors associated with relapse among opiate addicts in an out-patient detoxification programme. Br J Psychiatry 1992 11; 161: 654–7.CrossRefGoogle Scholar
30.Heather, N, Stallard, A, Tebbutt, J. Importance of substance cues in relapse among heroin users: comparison of two methods of investigation. Addict Behav 1991; 16(1–2): 41–9.CrossRefGoogle ScholarPubMed
31.Maulik, PK, Tripathi, BM, Pal, HR. Coping behaviors and relapse precipitants in opioid dependence: a study from North India. J Subst Abuse Treat 2002 04; 22(3): 135–40.CrossRefGoogle ScholarPubMed
32.Westphal, J, Wasserman, DA, Masson, CL, Sorenson, JL. Assessment of opioid use. In: Donovan, DM, Marlatt, GA, editors. Assessment of addictive behaviours. 2nd ed. New York: Guilford; 2005. p 215–47.Google Scholar
33.Smyth, BP, Barry, J, Lane, A, Cotter, M, O'Neill, M, Quinn, C, Keenan, E. In-patient treatment of opiate dependence: medium-term follow-up outcomes. Br J Psychiatry 2005 10; 187:360–5.CrossRefGoogle ScholarPubMed
34.Smyth, BP, Barry, J, Keenan, E, Ducray, K. Lapse and Relapse Following Inpatient Treatment of Opiate Dependence, IMJ 2010 06; 103(6): 176–79.Google ScholarPubMed
35.Veilleux, JC, Colvin, PJ, Anderson, J, York, C, Heinz, AJ. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 2010 03; 30(2):155–66.CrossRefGoogle ScholarPubMed
36.National Institute for Clinical Excellence (NICE): Drug Misuse: Opioid detoxification. The NICE guideline. London: National Institute for Health and Clinical Excellence, 2008.Google Scholar
37.Marsden, J, Gossop, M, Stewart, D, Best, D, Farrell, M, Lehmann, P, Edwards, C, Strang, J. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998 12; 93(12):1857–67.CrossRefGoogle ScholarPubMed
38.Gossop, M, Marsden, J, Stewart, D, Treacy, S. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav 2002 03-Apr; 27(2):155–66.CrossRefGoogle ScholarPubMed
39.Connors, GJ, Donovan, DM, Diclemente, CC. Substance Abuse Treatment and the stages of Change: Selecting and Planning Interventions. New York: Guilford Press; 2001.Google Scholar
40.McCrady, B. S.To have but one true friend: Implications for practice of research on alcohol use disorders and social networks. Psychology of Addictive Behaviors 2004; 18: 113–121.CrossRefGoogle Scholar
41.Beck, AT, Wright, FD, Newman, CF, Liese, BS. Cognitive Therapy of Substance Abuse. New York: Guilford Press; 1993.Google Scholar
42.Cummings, C, Gordon, JR, Marlatt, GA. Relapse: Prevention and prediction. In: Miller, WR, editor. The addictive behaviours. Oxford: Pergamon Press; 1980. p 291–321.Google Scholar
43.Marlatt, GA. Taxonomy of high-risk situations for alcohol relapse: evolution and development of a cognitive-behavioral model. Addiction 1996 12; 91 Suppl: S37–49.Google Scholar
44.European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Selected issue 3: Co-morbidity in Annual Report 2004: The state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities, 2004.Google Scholar
45.European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drugs in focus issue 14. Co-morbidity - drug use and mental disorders. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2005.Google Scholar
46.Drummond, DC, Litten, RZ, Lowman, C, Hunt, WA. Craving research: future directions. Addiction 2000 08; 95 Suppl 2: S247–55.CrossRefGoogle ScholarPubMed
47.Niaura, RS. Cognitive social learning and related perspectives on drug craving. Addiction 2000; 95:S155–S164.CrossRefGoogle ScholarPubMed
48.Marlatt, GA, Witkiewitz, K. Relapse prevention for alcohol and drug problems. In: Marlatt, GA, Donovan, DM, editors. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. 2nd ed. New York: Guilford Press; 2005. p 1–44.Google Scholar
49.Siegel, S. Drug Tolerance, Drug Addiction, and Drug Anticipation. Current Directions in Psychological Science 2005 12; 14: 296–300.CrossRefGoogle Scholar
50.Kadden, R, Carroll, KM, Donovan, D, Cooney, N, Monti, P, Abrams, D, Litt, M, Hester, R. Cognitive-behavioral coping skills therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism, 1992.Google Scholar
51.Carroll, KM. A Cognitive Behavioural Approach: Treating Cocaine Addiction. Rockville, MD: National Institute on Drug Abuse, 1998.Google Scholar
52.Hunt, GM, Azrin, NH. A community-reinforcement approach to alcoholism. Behav Res Ther 1973 02; 11(1): 91–104.CrossRefGoogle ScholarPubMed
53.Gossop, M. Treating drug misuse problems: evidence of effectiveness. London: National Treatment Agency for Substance Misuse, 2006.Google Scholar
54.Groh, DR, Jason, LA, Keys, CB. Social network variables in alcoholics anonymous: a literature review. Clin Psychol Rev 2008 03; 28(3): 430–50. Review.CrossRefGoogle ScholarPubMed
55.Gossop, M, Stewart, D, Marsden, J. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study. Addiction 2008 01;103(1):119–25.CrossRefGoogle ScholarPubMed
56.Ludwig, AM, Wikler, A. “Craving” and relapse to drink. Q J Stud Alcohol 1974 03; 35(1):108–30.CrossRefGoogle ScholarPubMed
57.Moos, RH. Theory-based active ingredients of effective treatments for substance use disorders. Drug Alcohol Depend 2007 05; 88(2–3): 109–21.CrossRefGoogle ScholarPubMed
58.Langendam, MW, van Haastrecht, HJ, van Ameijden, EJ. The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. Int J Epidemiol 1999 06; 28(3):514–20.CrossRefGoogle Scholar
59.Hammerbacher, M, Lyvers, M. Factors Associated with Relapse among Clients in Australian Substance Disorder Treatment Facilities. Journal of Substance Use 2006 11:6, 387–394.CrossRefGoogle Scholar
60.Gossop, M, Stewart, D, Brown, N, Marsden, J. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 2002; 97: 1259–1267.CrossRefGoogle ScholarPubMed
61.Wanigaratne, S, Davis, P, Pryce, K, Brotchie, J. The Effectiveness of Psychological Therapies on Drug-Misusing Clients. London: NTA; 2005.Google Scholar